Top Markets
Coin of the day
Celadon Pharmaceuticals Plc Celadon Pharmaceuticals Plc

Celadon Pharmaceuticals Plc

CEL
Classement en actions #40708
Celadon Pharmaceuticals Plc functions as a drug development company,... Celadon Pharmaceuticals Plc functions as a drug development company, concentrating on the discovery, production, and distribution of cannabinoid compounds for certified medical uses. The firm's primary activity involves the indoor, hydroponic cultivation of THC cannabis, which is then incorporated into medicinal products targeting chronic pain. Furthermore, Celadon intends to broaden its research into cannabinoids, exploring their therapeutic applications not only for persistent pain but also for conditions such as autism and multiple sclerosis. Established in 2018, the company maintains its headquarters in London, United Kingdom.
Prix de l'action
$0.00179028
Dernière synchronisation: 2025-07-28
Capitalisation boursière
$94.61K
Changement (1 jour)
-0.54%
Changement (1 an)
0.00%
Pays
GB
Échange Celadon Pharmaceuticals Plc (CEL)

Catégorie

Ratio P/B pour Celadon Pharmaceuticals Plc (CEL)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Celadon Pharmaceuticals Plc, le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Celadon Pharmaceuticals Plc de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes